5.100
+0,00%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +89.8% | +152.4% | 2 / 3 | -40.4% | +18.96 pp | +17.39 pp | +0.5% | 0.15 | 102.93 | 4,7 | −40,4% | −0,2 | +89,8% | 102.93 | 111.64 | −7,8% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 5.100 (close price on 2026-10-19)EPS (TTM): 49,5
Financial charts
1.Revenue & growth
VND bn4,96Q2/26
1.Revenue & growth
VND bn4,96Q2/26
2.Profit & growth
VND bn-0,11Q2/26
3.Profit mix (Penman)
VND bn0,65Q2/26
4.Margins & cost structure
%9.7%Q2/26
5.Returns & cash cycle
% · days-2.0%Q2/26
6.Earnings quality & cash
VND bn13,1Q2/26
7.Asset structure
VND bn148Q2/26
8.Funding & debt health
VND bn · times148Q2/26
9.Revenue backlog
VND bn3,21Q2/26
10.Valuation
times · %94,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-9Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
184%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26